$0+

Average Headcount Growth & Funding Per Employee, By Segment

0 ratings
I want this!

Average Headcount Growth & Funding Per Employee, By Segment

$0+
0 ratings

(Where) will money flow into kidney care in 2024?

Money is a tool. It's the fuel that allows companies to invest in top talent, new products, and future pipelines. It's also the thing that allows founders and fresh ideas to take flight. But despite billions of dollars invested into kidney care over the last few years, 2024 holds no prisoners and makes no promises. Certain sub-segments continue to get disproportionate levels of funding, while others face mounting losses in the so-called "valley of death" on their path to commercialization.

What's in this table

This table provides a focused look at four key segments driving kidney care innovation in 1Q24:

  • Value-Based Care (VBC)
  • Remote Patient Monitoring (RPM)
  • Diagnostics (hardware, software, and AI/ML)
  • Medical Devices (dialysis access and portable machines)

Key Insights

  • 8-10 venture-backed companies in each segment, all with at least 5 employees.
  • 1-year average headcount growth by segment, sourced from LinkedIn, offering directional trends in hiring.
  • Average funding per employee, a rough estimate of capital efficiency and resource needs across the industry.

Update: How quickly things can change. If you look at how these four segments have performed so far this year, you'll notice clear winners, big misses and unsustainable growth. This table was last updated December, 2023. Join the Signals Pro waitlist to get early access to our updated database and private messaging forum for innovators and key stakeholders.

Takeaways:

  1. Growth category leaders
  2. Capital efficiency category leaders
  3. Capital requirements by segment

Connect & Share

This graphic is free to download as part of my mission to make kidney care more accessible and actionable for innovators around the world. If you find this content helpful, please consider sharing Signals with 1 or 2 friends in the Kidneyverse.


About me & signals

I'm Tim Fitzpatrick. By day, I'm building IKONA; by night, I write Signals— curating & sharing lessons from the frontiers of kidney innovation, one [space] at a time. My goal is to make the frontiers of health more accessible, actionable, and backable. Join me and 15,000 monthly readers as we explore the Kidneyverse, one [space] at a time.

$
I want this!

Hi-res, print quality PDF

Copy product URL